SEC Form 4 · accession 0000899243-18-000380
MyoKardia Inc · MYOK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jake Bauer
Officer — See Remarks
Period of report
Jan 2, 2018
Accepted (ET)
Jan 3, 2018 · 8:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001552451
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jan 2, 2018 | S | 3,900 | $42.7566 | D | 62,877 | D | |
| Common StockF3 | Jan 2, 2018 | S | 1,100 | $43.3773 | D | 61,777 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F2Represents the weighted average sale price of the shares sold ranging from $42.20 to $43.15 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- F3Represents the weighted average sale price of the shares sold ranging from $43.20 to $43.60 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Remarks
Senior Vice President, Finance and Corporate Development